ZAVESCA (miglustat) capsules

Zavesca is a glucosylceramide synthase inhibitor indicated as monotherapy for treatment of adult patients with mild/moderate type 1 Gaucher disease for whom enzyme replacement therapy is not a therapeutic option.

Home | miglustat capsules

ZAVESCA (miglustat) capsules price in India and Overseas
ZAVESCA (miglustat) capsules

Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!

For Indian Patient Enquiry under NPP.

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

ZAVESCA (miglustat) capsules

Miglustat, sold under the brand name Zavesca among others, is a medication used to treat type I Gaucher disease (GD1) and Pompe disease. It is also known as N-butyldeoxynojirimycin, and is a derivative of the anti-diabetic 1-deoxynojirimycin.

Zavesca is a prescription medicine used alone to treat adults with mild to moderate type 1 Gaucher disease. Zavesca is used only in people who cannot be treated with
enzyme replacement therapy. It is not known if Zavesca is safe and effective in children under 18 years of age. Active ingredient: miglustat. Inactive ingredients: sodium starch glycollate, povidone (K30), and magnesium stearate.

Miglustat is indicated to treat adults with mild to moderate type I Gaucher disease for whom enzyme replacement therapy is unsuitable. In the EU, miglustat (Opfolda), in combination with cipaglucosidase alfa, is a long-term enzyme replacement therapy in adults with late-onset Pompe disease (acid α‑glucosidase [GAA] deficiency).

Drug (Brand / Generic): ZAVESCA / miglustat
Current Indications: chronic mild to moderate type 1 Gaucher disease
Marketed by:: Actelion
Approval Date: 2003

Available as (Form & Strength): Capsules: 100 mg. The capsule shell contains: gelatin and titanium dioxide; the edible printing ink contains black iron oxide and shellac.

For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here

Alleviare Life Sciences

About Us

Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.

Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.

Alleviare India, a certified pharmaceutical facilitator / supplier / importer of specialty medicines or drugs based in India.